Inclusion of Interactions in Mathematical Modelling of Implant Assisted Magnetic Drug Targeting

Drug delivery technologies are an important area within biomedicine. Targeted drug delivery aims to reduce the undesired side effects of drug usage by directing or capturing the active agents near a desired site within the body. This is particularly beneficial in, for instance, cancer chemotherapy, where the side effects of general (systemic) drug administration can be severe. One approach to targeted drug delivery uses magnetic nanoparticles as the constituents of carriers for the desired active agent. Once injected into the body, the behaviour of these magnetic carriers can be influenced and controlled by magnetic fields. In implant assisted magnetic drug targeting systems a magnetic implant, typically a stent, wire or spherical seed can be used to target sites deep within the body as the implant acts as a focus for the resulting magnetic force. This can be easily understood as the force depends on the gradient of the magnetic field and the gradient near the implant is large. In designing such a system many factors need to be considered including physical factors such as the size and nature of the implants and carriers, and the fields required. Moreover, the range of applicability of these systems in terms of the regions of the vasculature system, from low blood velocity environments, such as capillary beds to higher velocity arteries, must be considered. Furthermore, assessment criteria for these systems are needed. Mathematical modelling and simulation has a valuable role to play in informing in vitro and in vivo experiments, leading to practical system design. Specifically, the implant assisted magnetic drug targeting systems of Aviles. Ebner and Ritter are considered within this review, and two dimensional mathematical modelling is performed using the open source C++ finite volume library OpenFOAM. In the first system treated, a large ferromagnetic particle is implanted into a capillary bed as a seed to aid collection of single domain nanoparticles (radius 20-100 nm). The Langevin function is used to calculate the magnetic moment of the particles, and the model is further adapted to treat the agglomeration of particles known to occur in these systems. This agglomeration can be attributed to interparticle interactions and here the magnetic dipole-dipole and hydrodynamic interactions for two mutually interacting nanoparticles are modelled, following Mikkelsen et al. who treated two particle interactions in microfluidic systems, with low magnetic field (0.05 T). The resulting predicted performance is found to both increase and decrease significantly depending on initial positions of the particles. Secondly, a ferromagnetic, coiled wire stent is implanted in a large arterial vessel. The magnetic dipole-dipole and hydrodynamic interactions for multiple particles are included. Different initial positions are considered and the system performance is assessed. Inclusion of these interactions yields predictions that are in closer agreement with the experimental results of Aviles et al. We conclude that the discrepancies between the non interacting theoretical predictions and the corresponding experimental results can (as suggested by Aviles et al.) be largely attributed to interparticle interactions and the consequent agglomeration.

[1]  J. A. Ritter,et al.  In vitro study of magnetic particle seeding for implant assisted-magnetic drug targeting , 2008 .

[2]  Adil Mardinoglu,et al.  Calculation of nanoparticle capture efficiency in magnetic drug targeting , 2008 .

[3]  J. Coey,et al.  Magnetism and Magnetic Materials , 2001 .

[4]  M. Feliachi,et al.  Effect of the Magnetic Dipole–Dipole Interaction on the Capture Efficiency in Open Gradient Magnetic Separation , 2007, IEEE Transactions on Magnetics.

[5]  S. Loening,et al.  Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .

[6]  David Paul Hill,et al.  The computer simulation of dispersed two-phase flow , 1998 .

[7]  M. Shliomis REVIEWS OF TOPICAL PROBLEMS: Magnetic fluids , 1974 .

[8]  J. Frenkel,et al.  Spontaneous and Induced Magnetisation in Ferromagnetic Bodies. , 1930, Nature.

[9]  J. Simkin,et al.  On the use of the total scalar potential on the numerical solution of fields problems in electromagnetics , 1979 .

[10]  Samar Shah Numerical Simulation Of Particle Adhesion Dynamics For Applications In Nanomedicine And Biosensing , 2009 .

[11]  Armin D. Ebner,et al.  Application of high gradient magnetic separation principles to magnetic drug targeting , 2004 .

[12]  U. Häfeli,et al.  Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.

[13]  Håkan Nilsson Experiences with OpenFOAM for water turbine applications , 2007 .

[14]  Armin D. Ebner,et al.  Ferromagnetic seeding for the magnetic targeting of drugs and radiation in capillary beds , 2007 .

[15]  V. Adam,et al.  Magnetic nanoparticles and targeted drug delivering. , 2010, Pharmacological research.

[16]  Armin D. Ebner,et al.  Theoretical analysis of a transdermal ferromagnetic implant for retention of magnetic drug carrier particles , 2005 .

[17]  J. Richard Christman,et al.  Fundamentals of solid state physics , 1987 .

[18]  U. Häfeli,et al.  Radiolabeling of magnetic particles with rhenium-188 for cancer therapy , 2001 .

[19]  D. Mattis The Theory of Magnetism Made Simple:An Introduction To Physical Concepts And To Some Useful Mathematical Methods , 2006 .

[20]  D. Rancourt Magnetism of Earth, Planetary, and Environmental Nanomaterials , 2001 .

[21]  W. Coffey,et al.  On the theory of Debye and Néel relaxation of single domain ferromagnetic particles , 2007 .

[22]  William Fuller Brown,et al.  Magnetostatic principles in Ferromagnetism , 1962 .

[23]  S. Veintemillas-Verdaguer,et al.  Contrast agents for MRI based on iron oxide nanoparticles prepared by laser pyrolysis , 2003 .

[24]  Mikkel Fougt Hansen,et al.  Theoretical comparison of magnetic and hydrodynamic interactions between magnetically tagged particles in microfluidic systems , 2005 .

[25]  C Alexiou,et al.  Clinical applications of magnetic drug targeting. , 2001, The Journal of surgical research.

[26]  Armin D. Ebner,et al.  Isolated swine heart ventricle perfusion model for implant assisted-magnetic drug targeting. , 2008, International journal of pharmaceutics.

[27]  R. Felix,et al.  MRI after magnetic drug targeting in patients with advanced solid malignant tumors , 2004, European Radiology.

[28]  J. P. Jakubovics,et al.  Magnetism and magnetic materials , 1994 .

[29]  H. Hofmann,et al.  Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system , 2005 .

[30]  C. Bárcena,et al.  APPLICATIONS OF MAGNETIC NANOPARTICLES IN BIOMEDICINE , 2003 .

[31]  Series expansions for the magnetisation of a solid superparamagnetic system of non-interacting particles with anisotropy , 1999 .

[32]  D. A. Dunnett Classical Electrodynamics , 2020, Nature.

[33]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[34]  Adriele Prina-Mello,et al.  Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targetingapplication , 2011 .

[35]  Aleksandar Jemcov,et al.  OpenFOAM: A C++ Library for Complex Physics Simulations , 2007 .

[36]  J. A. Ritter,et al.  Biodegradable Nanocomposite Magnetite Stent for Implant-Assisted Magnetic Drug Targeting , 2010 .

[37]  Dar-Bin Shieh,et al.  Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. , 2005, Biomaterials.

[38]  J. A. Ritter,et al.  In vitro study of magnetic nanoparticles as the implant for implant assisted magnetic drug targeting , 2011 .

[39]  Armin D. Ebner,et al.  Magnetizable implants and functionalized magnetic carriers: A novel approach for noninvasive yet targeted drug delivery , 2005 .

[40]  R. Gilchrist,et al.  Selective Inductive Heating of Lymph Nodes , 1957, Annals of surgery.

[41]  O. Ubbink Numerical prediction of two fluid systems with sharp interfaces , 1997 .

[42]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[43]  H. Bruus,et al.  Magnetic Separation and Hydrodynamic Interactions in Micro∞uidic Systems , 2005 .

[44]  Armin D. Ebner,et al.  Implant assisted-magnetic drug targeting : Comparison of in vitro experiments with theory , 2008 .

[45]  C. Berry Possible exploitation of magnetic nanoparticle–cell interaction for biomedical applications , 2005 .

[46]  Catherine C. Berry,et al.  Functionalisation of magnetic nanoparticles for applications in biomedicine , 2003 .

[47]  Q. Pankhurst,et al.  Progress in applications of magnetic nanoparticles in biomedicine , 2009 .

[48]  Pedro Tartaj,et al.  Progress in the preparation of magnetic nanoparticles for applications in biomedicine , 2009 .

[49]  Carl K. Hoh,et al.  Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy , 1999 .

[50]  Hrvoje Jasak,et al.  Error analysis and estimation for the finite volume method with applications to fluid flows , 1996 .

[51]  H. Bryant,et al.  Magnetic needles and superparamagnetic cells , 2007, Physics in medicine and biology.

[52]  W Finck,et al.  Biocompatible magnetic polymer carriers for in vivo radionuclide delivery. , 1999, Artificial Organs.

[53]  Peter Babinec,et al.  Lysis of photosensitized erythrocytes in an alternating magnetic field , 2001 .

[54]  Adil Mardinoglu,et al.  Inclusion of magnetic dipole–dipole and hydrodynamic interactions in implant-assisted magnetic drug targeting , 2009 .

[55]  U. Häfeli,et al.  Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo. , 2004, Biorheology.

[56]  Catherine C. Berry,et al.  Progress in functionalization of magnetic nanoparticles for applications in biomedicine , 2009 .

[57]  Giles Richardson,et al.  Mathematical modelling of magnetically targeted drug delivery , 2005 .

[58]  K. Widder,et al.  Magnetic guidance of drug‐carrying microspheres , 1978 .

[59]  E. P. Furlani,et al.  A model for predicting magnetic targeting of multifunctional particles in the microvasculature , 2006, physics/0612116.

[60]  R. Becker Electromagnetic fields and interactions , 1982 .

[61]  Tommy Olsson,et al.  The use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapy. , 2010, Biomaterials.

[62]  Armin D. Ebner,et al.  Analysis of magnetic drug carrier particle capture by a magnetizable intravascular stent—2: Parametric study with multi-wire two-dimensional model , 2005 .

[63]  J.G. Williams,et al.  Predicting residual stresses due to solidification in cast plastic plates , 2000 .

[64]  Armin D. Ebner,et al.  In vitro study of ferromagnetic stents for implant assisted-magnetic drug targeting , 2007 .

[65]  H. Rusche Computational fluid dynamics of dispersed two-phase flows at high phase fractions , 2003 .

[66]  A. Mardinoğlu,et al.  Many particle magnetic dipole–dipole and hydrodynamic interactions in magnetizable stent assisted magnetic drug targeting , 2010 .

[67]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[68]  G. Storm,et al.  ACTIVE TARGETING WITH PARTICULATE CARRIER SYSTEMS IN THE BLOOD COMPARTMENT , 1995 .

[69]  Kenneth A. Barbee,et al.  Targeted drug delivery to magnetic implants for therapeutic applications , 2005 .

[70]  Witold Dzwinel,et al.  A discrete-particle model of blood dynamics in capillary vessels. , 2003, Journal of colloid and interface science.

[71]  D. Mattis,et al.  The Theory of Magnetism I , 1981 .

[72]  J. W. Brown Thermal Fluctuations of a Single-Domain Particle , 1963 .

[73]  A. Ampere,et al.  Théorie mathématique des phénomènes électro-dynamiques uniquement déduite de l'expérience , 1958 .

[74]  Hrvoje Jasak,et al.  A tensorial approach to computational continuum mechanics using object-oriented techniques , 1998 .

[75]  D. Crothers,et al.  An approximate formula for the relaxation time of a single domain ferromagnetic particle with uniaxial anisotropy and collinear field , 1994 .